Incidence of Thromboembolic Events in Cancer Hospitalized Patients With COVID-19
Chest
.
2021 Jun;159(6):2512-2513.
doi: 10.1016/j.chest.2021.01.022.
Authors
Jacobo Rogado
1
,
Berta Obispo
2
,
Nuria Muñoz-Rivas
3
,
Miguel Angel Lara
4
;
Infanta Leonor Thrombosis Research Group
Collaborators
Infanta Leonor Thrombosis Research Group
:
B Mestre-Gómez
,
R M Lorente-Ramos
,
J Rogado
,
A Franco-Moreno
,
B Obispo
,
D Salazar-Chiriboga
,
T Saez-Vaquero
,
J Torres-Macho
,
A Abad-Motos
,
C Cortina-Camarero
,
A Such-Diaz
,
E Ruiz-Velasco
,
N Muñoz-Rivas
,
F Sierra-Hidalgo
,
E Moya-Mateo
,
M de Carranza-López
,
M A Herrera-Morueco
,
M Akasbi-Montalvo
,
V Pardo-Guimerá
,
P Medrano-Izquierdo
,
E Mariscal-Gómez
,
K Marín-Mori
,
C Figueras-González
,
S López-Lallave
,
D Díaz-Díaz
,
C Mauleón-Fernández
,
J Martín-Navarro
,
P Torres-Rubio
,
C Matesanz
,
M J Moro-Alvarez
,
A Bustamante-Fermosel
,
J A Hernández-Rivas
Affiliations
1
Medical Oncology Department, Madrid, Spain. Electronic address: jacobo.rogado@gmail.com.
2
Medical Oncology Department, Madrid, Spain.
3
Thromboembolic Disease Division, Internal Medicine Department, Hospital Universitario Infanta Leonor, Madrid, Spain.
4
Medical Oncology Department, Madrid, Spain; Universidad Complutense, Madrid, Spain.
PMID:
34099141
PMCID:
PMC8175943
DOI:
10.1016/j.chest.2021.01.022
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Humans
Incidence
Neoplasms* / complications
Neoplasms* / epidemiology
SARS-CoV-2
Venous Thromboembolism*